Alvotech Analyst Price Targets - Benzinga

SPY779.93+0.11%QQQ759.99+0.04%BTC/USD85,547.23−0.24%DIA514.87+0.06%GLD381.53−0.19%TLT77.25−0.04%

Alvotech

ALVONASDAQ

Trade with Public

Trade with Public

$6.14

0.030.49%

Last update: Oct 6, 4:59 PM

$6.24

0.132.14%

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Compare Stock Report

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investor Events
Pre-market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

© 2026 Benzinga | All Rights Reserved

Alvotech Analyst Price Targets - Benzinga

Alvotech Analyst Price Targets

Wall Street analyst price targets and consensus rating for Alvotech (ALVO).

Price Target Range — 9 Quarters

Analyst Consensus — 7 Analysts

5Buy

2Hold

Consensus RatingBuy# Analysts7Avg. Consensus PT$11Upside to Avg. PT+70.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 16, 2026	Barclays	Glen Santangelo	Upgrade	Underweight→Overweight	$4→$8
Aug 24, 2026	B of A Securities	Jason Gerberry	Initiate	Buy	$7
Aug 14, 2026	Evercore ISI Group	Umer Raffat	Initiate	Outperform	—
Mar 24, 2026	UBS	Ashwani Verma	PT Cut	Buy	$10→$6
Mar 24, 2026	Barclays	Glen Santangelo	PT Cut	Underweight	$5→$4
Dec 9, 2025	Barclays	Glen Santangelo	Initiate	Underweight	$5
Nov 18, 2025	UBS	Ashwani Verma	PT Cut	Buy	$13→$10
Nov 4, 2025	Deutsche Bank	Niall Alexander	Downgrade	Buy→Hold	$14→$8
Oct 14, 2025	Morgan Stanley	Thibault Boutherin	Upgrade	Equal-Weight→Overweight	$14
Sep 23, 2025	Deutsche Bank	Niall Alexander	Upgrade	Hold→Buy	$14
Jul 18, 2025	UBS	—	PT Cut	Buy	$16→$14
Feb 14, 2025	UBS	—	Initiate	Buy	$18
Jul 25, 2024	Barclays	Balaji Prasad	PT Cut	Overweight	$22→$18
May 24, 2024	Barclays	Balaji Prasad	PT Raise	Overweight	$20→$22
Mar 22, 2024	Barclays	Balaji Prasad	PT Raise	Overweight	$17→$20
Jan 29, 2024	Barclays	Balaji Prasad	Upgrade	Equal-Weight→Overweight	$10→$17
Oct 20, 2023	Citigroup	Andrew Baum	Upgrade	Sell→Neutral	$5→$10

More with Benzinga EdgeGet Access

Analyst Ratings News

Rapport Therapeutics To Rally Around 76%? Here Are 10 Top Analyst Forecasts For Wednesday

Analysts raised targets for RAPP, ALLR, UNP and ALVO; cut targets for NU, CLLS and JBHT, with several rating upgrades and downgrades.

Avi Kapoor

This Union Pacific Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday

Analysts upgraded Similarweb, Rocket Pharmaceuticals, Radiant Logistics and Ulta Beauty; Paychex rose to Peer Perform, with targets raised.

Avi Kapoor

PRO
Barclays Upgrades Alvotech to Overweight, Raises Price Target to $8

Barclays analyst Glen Santangelo upgrades Alvotech (NASDAQ:ALVO) from Underweight to Overweight and raises the price target from $4 to $8.

Benzinga Newsdesk

PRO
B of A Securities Initiates Coverage On Alvotech with Buy Rating, Announces Price Target of $7

B of A Securities analyst Jason Gerberry initiates coverage on Alvotech (NASDAQ:ALVO) with a Buy rating and announces Price Target of $7.

Benzinga Newsdesk

PRO
Evercore ISI Group Initiates Coverage On Alvotech with Outperform Rating

Evercore ISI Group analyst Umer Raffat initiates coverage on Alvotech (NASDAQ:ALVO) with a Outperform rating.

Benzinga Newsdesk

PRO
UBS Maintains Buy on Alvotech, Lowers Price Target to $6

UBS analyst Ashwani Verma maintains Alvotech (NASDAQ:ALVO) with a Buy and lowers the price target from $10 to $6.

Benzinga Newsdesk